[1]
“Anti- Cytomegalovirus antibodies, TNF- α, IL-19, CD4, CD163, and VEGF-A serum levels in Patients with Breast Cancer: Anti- Cytomegalovirus antibodies, TNF- α, IL-19, CD4, CD163, and VEGF-A serum levels in Patients with Breast Cancer”, Acad. J. Int. Univ. Erbil, vol. 2, no. 04, pp. 534–540, Oct. 2025, doi: 10.63841/iue24500.